# Generix Global Investment — NAFDAC-Registered Products & Company Profile

Generix Global Investment holds 5 active NAFDAC product registrations in our October 2026 copy of the Greenbook.

- Source: https://ogbogwu.com/manufacturers/generix-global-investment/
- NAFDAC-registered products: 5 · Diabetes, Pain & Fever
- Made in: Bangladesh (4), India (1)
- Address & phone: Not on record — the NAFDAC Greenbook lists products, not offices.
- Rank by registered products: 338 of 533 manufacturers tracked (October 2026 copy)
- Nigerian company: no

## Register profile (October 2026 copy)

Generix Global Investment has 5 products registered with NAFDAC for the Nigerian market in our October 2026 copy of the Greenbook. The full list below is compiled from that copy of the NAFDAC Greenbook — Nigeria's official register of approved products.
Its medicines are strongest in Diabetes (3 products) and Pain & Fever (1 product). Registered brands include Linajen-M 2.5/1000 Tablet, Pentazocine Injection 30 mg/mL and Progerix Tablet. Most of its products are registered as tablet and solution for injection formulations. 4 of its products link through to full Ogbogwu drug guides covering uses, dosage, prices, and NAFDAC verification. Generix Global Investment is the registration holder rather than the physical maker: the Greenbook records factories abroad for its products (mostly Bangladesh).

## Product categories (October 2026 copy)

- Diabetes: 3 products
- Pain & Fever: 1 product

## Registered products in our October 2026 copy

| Product | NAFDAC Reg. No. | Strength | Form |
|---|---|---|---|
| Linajen-M 2.5/1000 Tablet | A4-100158 | 1000 mg; 2.5 mg | Tablet |
| Linajen-M 2.5/500 Tablet | A4-100159 | 500 mg; 2.5 mg | Tablet |
| Pentazocine Injection 30 mg/mL | A4-100946 | 30 mg/mL | Solution for injection |
| Progerix Tablet | A4-100399 | 10 mg | Tablet |
| Xyvida Vildagliptin 50 mg Tablets | A4-100396 | 50 mg | Tablet |

Verify any NAFDAC number free: https://ogbogwu.com/nafdac-checker/